BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Vrije Universiteit Amsterdam//NONSGML v1.0//EN
NAME:PhD defence M.V. Pozo Garcia
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART:20260417T114500
DTEND:20260417T131500
DTSTAMP:20260417T114500
UID:2026/phd-defence-m-v-pozo-garc@8F96275E-9F55-4B3F-A143-836282E12573
CREATED:20260418T230311
LOCATION:Hoofdgebouw, Aula De Boelelaan 
 1105 1081 HV  Amsterdam
SUMMARY:PhD defence M.V. Pozo Garcia
X-ALT-DESC;FMTTYPE=text/html: <html> <body> <p>From Spectra to Pathway
 s: Assessing Metabolic Function and Nutrient Modulation of Liver In V
 itro Systems by LC-MS metabolomics</p> <h3><strong>New step in drug r
 esearch: improved insight into liver function thanks to advanced anal
 ytical technique</strong></h3><p>Biochemist Victoria Pozo Garcia has 
 made a significant advance in improving in vitro laboratory models of
  the liver. Using an advanced technique- liquid chromatography couple
 d with mass spectrometry (LC-MS)- she was able to map more precisely 
 how these models process drugs and how their metabolism functions.</p
 ><p>Her research shows that these so-called in vitro liver systems ca
 n be evaluated more effectively by looking not only at individual enz
 ymatic reactions, but at entire metabolic pathways. By applying LC-MS
  metabolomics, Pozo Garcia also identified which nutrients in the cul
 ture medium influence the maturation of liver cells in the lab. This 
 is crucial, as better-developed liver models can make more reliable p
 redictions about the efficacy and safety of new drugs.</p><p><strong>
 Personalized medicine</strong><br>A notable outcome is the combinatio
 n of stem cell technology with this analytical method. This makes it 
 possible to model hepatic responses based on individual donors. In tu
 rn, this opens the door to personalized medicine: researchers can pre
 dict, for each individual, how drugs are metabolized and whether pote
 ntially harmful byproducts are formed. It also becomes easier to dete
 ct disruptions in metabolism, for example due to disease or exposure 
 to xenobiotic substances.</p><p>More reliable laboratory models can m
 ake the drug development process safer and more efficient. In additio
 n, the use of animal testing could be reduced over time as better alt
 ernatives become available. Although animal models are still needed f
 or now, these findings mark a clear step toward more ethical and pati
 ent-centered drug development.</p><p>More information on the <a href=
 "https://hdl.handle.net/1871.1/1da71055-1157-4ba0-82c8-ab5bca024efe" 
 data-new-window="true" target="_blank" rel="noopener noreferrer">thes
 is</a></p> </body> </html>
DESCRIPTION: <h3><strong>New step in drug research: improved insight i
 nto liver function thanks to advanced analytical technique</strong></
 h3> Biochemist Victoria Pozo Garcia has made a significant advance in
  improving in vitro laboratory models of the liver. Using an advanced
  technique- liquid chromatography coupled with mass spectrometry (LC-
 MS)- she was able to map more precisely how these models process drug
 s and how their metabolism functions. Her research shows that these s
 o-called in vitro liver systems can be evaluated more effectively by 
 looking not only at individual enzymatic reactions, but at entire met
 abolic pathways. By applying LC-MS metabolomics, Pozo Garcia also ide
 ntified which nutrients in the culture medium influence the maturatio
 n of liver cells in the lab. This is crucial, as better-developed liv
 er models can make more reliable predictions about the efficacy and s
 afety of new drugs. <strong>Personalized medicine</strong><br>A notab
 le outcome is the combination of stem cell technology with this analy
 tical method. This makes it possible to model hepatic responses based
  on individual donors. In turn, this opens the door to personalized m
 edicine: researchers can predict, for each individual, how drugs are 
 metabolized and whether potentially harmful byproducts are formed. It
  also becomes easier to detect disruptions in metabolism, for example
  due to disease or exposure to xenobiotic substances. More reliable l
 aboratory models can make the drug development process safer and more
  efficient. In addition, the use of animal testing could be reduced o
 ver time as better alternatives become available. Although animal mod
 els are still needed for now, these findings mark a clear step toward
  more ethical and patient-centered drug development. More information
  on the <a href="https://hdl.handle.net/1871.1/1da71055-1157-4ba0-82c
 8-ab5bca024efe" data-new-window="true" target="_blank" rel="noopener 
 noreferrer">thesis</a> From Spectra to Pathways: Assessing Metabolic 
 Function and Nutrient Modulation of Liver In Vitro Systems by LC-MS m
 etabolomics
END:VEVENT
END:VCALENDAR
